Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12

Journal of Clinical Investigation

Volumn 97, Issue 6, 1996, Pages 1550-1555

  Blauvelt, Andrew ^a   Chougnet, Claire ^a   Shearer, Gene M ^a   Katz, Stephen I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AIDS; antigen presenting cells; cytokines; dendritic cells; immunotherapy

Indexed keywords

CYTOKINE; DIDANOSINE; INTERLEUKIN 10; INTERLEUKIN 2; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 12; STAVUDINE; TETANUS TOXOID; VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; LEUKOCYTE COUNT; MALE; MONOZYGOTIC TWINS; PRIORITY JOURNAL;

EID: 0029870407     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118578     Document Type: Article

References (65)

1. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity, Annu. Rev. Immunol. 9:271-296.
2. Schuler, G., editor. Epidermal Langerhans Cells. 1991. CRC Press, Inc., Boca Raton, FL. 324 pp.
3. Tschachler, E., V. Groh, M. Popovic, D.L. Mann, K. Konrad, B. Safai, L. Eron, F. diMarzo Veronese, K. Wolff, and G. Stingl. 1987. Epidermal Langerhans cells. A target for HTLV-III/LAV infection. J. Invest. Dermatol. 88:233-237.
4. Macatonia, S.E., R. Lau, S. Patterson, A.J Pinching, and S.C. Knight. 1989. Suppression of immune responses by dendritic cells infected with HIV. Immunology. 67-285-289.
5. Macatonia, S.E , R. Lau, S. Patterson, A.J. Pinching, and S.C. Knight. 1990. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology. 71:38-45.
6. Langhoff, E., E.F. Terwilliger, H J. Bos, K.H. Kalland, M C. Poznansky, O.M.L. Bacon, and W.A. Haseltine. 1991. Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. Proc. Natl. Acad Sci. USA. 88:7998-8002.
7. + cells. Science (Wash DC). 257:383-387.
8. Berger, R., S. Gartner, K. Rappersberger, C.A. Foster, K. Wolff, and G. Stingl. 1992. Isolation of human immunodeficiency virus type 1 from human epidermis: virus replication and transmission studies. J. Invest. Dermatol. 99: 271-277.
9. Chehimi, J., K. Prakash, V. Shanmugam, R. Collman, S.J. Jackson, S. Bandyopadhyay, and S.E. Starr. 1993. CD4-independent infection of human blood dendritic cells with isolates of human immunodeficiency virus type 1. J. Gen Virol. 74:1277-1285.
10. Giannetti, A., G Zambruno, A. Cimarelli, A. Marconi, M. Negroni, G. Girolomoni, and U. Bertazzoni. 1993. Direct detection of HIV RNA in epidermal Langerhans cells of HIV-infected patients. J. Acquir. Immune Defic. Syndr. 6:329-333.
11. Henry, M., A. Uthman, C. Ballaun, G. Stingl, and E. Tschachler. 1994. Epidermal Langerhans cells of AIDS patients express HIV-1 regulatory and structural genes. J. Invest. Dermatol. 103:593-596.
12. + blood dendritic cells are potent producers of IFN-α in response to in vitro HIV-1 infection. J. Immunol. 152:4649-4662.
13. + T cells during an immune response to HIV-1-pulsed dendritic cells. AIDS Res. Hum. Retroviruses. 10:61-71.
14. Pope, M., M.G.H. Betjes, N. Romani, P.U. Cameron, L. Hoffman, S. Gezelter, G. Schuler, and R.M. Steinman 1994. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell. 78:389-398.
15. Pinchuk, L.M , P S. Polacino, M.B. Agy, S.J Klaus, and E.A. Clark 1994. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity. 1:317-325.
16. Weissman, D., Y. Li, J. Ananworanich, L.J. Zhou, J. Adelsberger, T.F. Tedder, M. Baseler, and A.S. Fauci. 1995. Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 92:826-830.
17. Knight, S C., S.E. Macatonia, and S. Patterson. 1990. HIV 1 infection of dendritic cells. Int. Rev. Immunol. 6:163-175.
18. Stingl, G., K Rappersberger, E. Tschachler, S. Gartner, V. Groh. D L Mann, K. Wolff, and M. Popovic. 1990. Langerhans cells and HIV-1 infection. J. Am Acad. Dermatol. 22:1210-1217.
19. Meyaard, L., H. Schuitemaker, and F. Miedema. 1993. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function? Immunol. Today. 14:161-164.
20. Helbert, M.R., J L'age-Stehr, and N.A. Mitchison. 1993. Antigen presentation, loss of immunological memory and AIDS Immunol. Today. 14:340-344.
21. Eales, L.J., J. Farrant, M. Helbert, and A.J. Pinching. 1988. Peripheral blood dendritic cells in persons with AIDS related complex: loss of high intensity class II antigen expression and function. Clin. Exp. Immunol. 71:423-427.
22. Macatonia, S.E., M. Gompels, A.J. Pinching, S. Patterson, and S.C. Knight. 1992. Antigen presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. Immunology. 75 576-581.
23. - T cells clonal expansion. Clin. Exp. Immunol. 88:226-236.
24. Blauvelt, A., M. Clerici, D.R. Lucey, S.M. Steinberg, R. Yarchoan, R. Walker, G.M. Shearer, and S.I. Katz. 1995. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J. Immunol 154:3506-3515.
25. Clerici, M., and G.M. Shearer. 1993. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today. 14:107-111.
26. Clerici, M., and G.M. Shearer. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today. 15:575-581.
27. Clerici, M., F.H. Hakim, D.J. Venzon, S. Blatt, C.W. Hendrix, T A. Wynn, and G.M. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individu als. J. Clin. Invest. 91:759-765.
28. + T-cell clones in human immunodeficiency virus infection Blood. 84:4262-4268.
29. + T cells to a TH2 phenotype and its possible relationship to the onset of AIDS. Res. Immunol. 145:643-646.
30. Clerici, M., T A Wynn, J.A. Berzofsky, S.P. Blatt, C.W. Hendrix, A. Sher, R.L. Coffman, and G.M. Shearer. 1994. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin Invest. 93:768-775.
31. Barcellini, W., G.P. Rizzardi, C. Velati, M.O. Borghi, C. Fain, A. Lazzarin, and P.L Meroni. 1995. In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users. AIDS (Phila.). 9:691-694.
32. Clerici, M., D.R. Lucey, J.A Berzofsky, L.A. Pinto, T.A. Wynn, S P. Blatt, M.J. Dolan, C.W. Hendrix, S F. Wolf, and G.M. Shearer. 1993. Restoration of HIV-specific cell-mediated immune response by interleukin-12 in vitro. Science (Wash DC). 262:1721-1724.
33. Zhang, M., J. Gong, D.V. Iyer, B.E. Jones, R.L. Modlin, and P.F. Barnes. 1994. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection J. Clin. Invest. 94:2435-2442
34. Centers for Disease Control and Prevention 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults Morb. Mortal. Wkly. Rep. 41:1-19.
35. + melanophages appear in human epidermis after ultraviolet radiation. J. Invest. Dermatol. 86:363-370.
36. + cell numbers and clinical staging. J. Clin. Invest. 84:1842-1899.
37. Cimarelli, A , G. Zambruno, A. Marconi, G. Girolomoni, U. Bertazzoni, and A. Giannetti. 1994. Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. J. Acquir. Immune Defic. Syndr. 7:230-235.
38. Kirkpatrick, C.H., K.C. Davis, and C.R Horsburgh. 1984. Reduced la-positive Langerhans cells in AIDS. N. Engl. J Med. 311:857-858.
39. Fauci, A.S. 1987. AIDS: immunopathogenic mechanisms and research strategies. Clin. Res. 35:503-510.
40. Rich, E A., Z. Toossi, H Fujiwara, R Hanigosky, M.M. Lederman, and J J. Ellner. 1988. Defective accessory function of macrophages in human immunodeficiency virus-related disease syndromes. J. Lab. Clin. Med. 112:174-181.
41. Hofmann, B., N. Odum, B.K. Jakobsen, P. Platz, L.P. Ryder, J.O. Niclsen, J. Gerstoft, and A. Svejgaard. 1986. Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defectinvestigated by mixing AIDS cells with HLA-DR identical normal cells. Scand. J Immunol. 23:669-678.
42. Clerici, M., N.I. Stocks, R.A. Zajac, R.N Boswell, and G.M. Shearer. 1990. Accessory cell function in asymptomatic human immunodeficiency virus-infected patients. Clin. Immunol. Immunopathol. 54:168-173.
43. Chehimi, J., and G Trinchieri. 1994 Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. 14:149-161.
44. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027.
45. Chehimi, J., S.E. Starr. I Frank, M. Rengaraju, S J. Jackson, C. Llanes, M. Kobayashi, B Perussia, D. Young, E. Nickbarg, S. Wolff, and G. Trinchieri. 1992. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175:789-796.
46. Chehimi, J., S.E. Starr, I. Frank, A. D'Andrea, X. Ma, R.R. MacGregor, J Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361-1366.
47. Germann, T., M.K. Gately, D.S Schoenhaut, M. Lohoff, F. Mattner, S. Fischer, S.C. Jin, E. Schmitt, and E. Rude. 1993. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells Eur. J. Immunol. 23:1762-1770.
48. Seville, M.W., K. Taga, A. Foli, S. Broder, G Tosato, and R. Yarchoan. 1994 Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage. Blood 83:3591-3599.
49. Weissman, D., G. Poli, and A.S. Fauci. 1994. Interleukin-10 blocks HIV replication in macrophages by inhibiting the autocrine loop of TNF-α and IL-6. AIDS Res Hum Retroviruses. 10:1199-1206.
50. Akridge, R.E., L.K.M. Oyafuso, and S.G. Reed. 1994. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages J. Immunol. 153 5782-5789.
51. Montaner, L.J., P. Griffin, and S. Gordon. 1994. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro. J. Gen. Virol 75.3393-3400.
52. Masood, R., Y. Lunardi-Iskandar, T. Moudgil, Y. Zhang, R.E. Law, C.-L. Huang, R.K. Puri, A.M. Levine, and P.S. Gill. 1994. IL-10 inhibits HIV-1 replication and is induced by tat Biochem. Biophys. Res. Commun 202:374-383.
53. Kootstra, N.A , A.B van'tWout, H.G. Huisman, F. Miedema, and H. Schuitemaker. 1994. Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages. J Virol. 68:6967-6975.
54. Borghi, P., L. Fantuzzi, B. Varano, S. Gessani, P. Paddu, L. Conti, M.R. Capobianchi, F. Ameglio, and F. Belardelli. 1995. Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J. Virol. 69:1284-1287.
55. 54a. Weissman, D., J. Daucher, T. Barker, J Adelsberger, M. Baseler, and A.S. Fauci 1996 Cytokine regulation of HIV replication induced by dendritic cell-CD4 positive T cell interactions. AIDS Res. Hum. Retroviruses. In press.
56. Graziosi, C., G. Pantaleo, K.R. Gantt, J.P. Fortin, J.F. Demarest, O.J. Cohen, R.P Sekaly, and A.S. Fauci. 1994 Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science (Wash. DC). 265.248-252.
57. Enk, A.M., V.L. Angeloni, M.C. Udey, and S.I. Katz. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10. J. Immunol. 151:2390-2398.
58. Beissert, S., J. Hosoi, S. Grabbe, A. Asahina, and R.D. Granstein. 1995. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells J Immunol. 154:1280-1286.
59. Mitra, R.S., T.A. Judge, F.O. Nestle, L.A. Turka, and B.J. Nickoloff. 1995. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. J. Immunol. 154:2668-2677.
60. de Waal Malefyt, R., J. Haanen, H. Spits, M.G Roncarolo, A. teVelde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J.E. deVries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174.915
61. Ding, L , P.S. Linsley, L Y. Huang, R N. Germain, and E.M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224-1234.
62. Chernoff, A.E , E.V. Granowitz, L. Shapiro, E Vannier, G Lonnemann, J.B. Angel, J.S Kennedy, A.R. Rabson, S.M. Wolff, and C.A. Dinarello 1995. A randomized, controlled trial of IL-10 in humans. J. Immunol 154:5492-5499.
63. + T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J Exp. Med. 181:423-428.
64. + T cells. J Clin. Invest. 94:797-807
65. Matsuda, M., F. Salazar, M. Petersson, G Masucci, J. Hansson, P. Pisa, Q.J. Zhang, M.G. Masucci, and R. Kiessling. 1994. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class 1 expression. J. Exp. Med. 180:2371-2376.